| XLS |
|
|
|
||
€ million |
Jan.–June 2014 |
Jan.–June 2013 |
||
|
||||
Profit after tax |
633.4 |
585.1 |
||
Depreciation/amortization/impairment losses/reversals of impairments |
627.9 |
682.1 |
||
Changes in inventories |
–7.2 |
–43.4 |
||
Changes in trade accounts receivable |
–88.0 |
–135.4 |
||
Changes in trade accounts payable |
–19.6 |
37.8 |
||
Changes in provisions |
–89.0 |
2.8 |
||
Changes in other assets and liabilities |
–215.2 |
–131.0 |
||
Neutralization of gain/loss on disposals of assets |
–11.8 |
–37.4 |
||
Other non-cash income and expenses |
7.5 |
–2.3 |
||
Net cash flows from operating activities |
838.1 |
958.2 |
||
|
|
|
||
Payments for investments in intangible assets |
–39.0 |
–50.2 |
||
Payments for investments in property, plant and equipment |
–142.1 |
–157.2 |
||
Payments from the sale of property, plant and equipment1 |
4.0 |
256.7 |
||
Payments for investments in financial assets1 |
–506.2 |
–725.5 |
||
Payments for the obtainment of control over AZ Electronic Materials S.A. less acquired cash and cash equivalents |
–1,419.4 |
– |
||
Payments for other acquisitions |
– |
–15.1 |
||
Payments from the disposal of investments1 |
1,948.5 |
99.3 |
||
Payments from the divestment of the Discovery and Development Solutions business field |
20.7 |
– |
||
Net cash flows from investing activities |
–133.6 |
–592.0 |
||
|
|
|
||
Dividend payments to Merck KGaA shareholders1 |
–122.8 |
–109.9 |
||
Dividend payments to non-controlling interests1 |
–2.7 |
–3.0 |
||
Withdrawals from retained earnings by E. Merck KG1 |
–383.0 |
–304.5 |
||
Payments from new borrowings of financial liabilities from E. Merck1 |
275.8 |
213.6 |
||
Payments for the acquisition of shares in AZ Electronic Materials S.A. after obtainment of control |
–348.3 |
– |
||
Changes in other current and non-current financial liabilities |
–267.2 |
–17.9 |
||
Net cash flows from financing activities |
–848.4 |
–221.7 |
||
|
|
|
||
Changes in cash and cash equivalents |
–143.9 |
144.5 |
||
Changes in cash and cash equivalents due to currency translation |
9.7 |
–9.8 |
||
Cash and cash equivalents as of January 1 |
980.8 |
729.7 |
||
Cash and cash equivalents as of June 30 |
846.6 |
864.4 |
||
Plus cash and cash equivalents included in assets held for sale |
– |
– |
||
Cash and cash equivalents as of June 30 (consolidated balance sheet) |
846.6 |
864.4 |
||